Search Site
Contact Details

CALL: +44 (0)8446 696907

Contact Details
InflammaDry

AN IN-PRACTICE TEST TO AID IN DRY EYE DIAGNOSIS

InflammaDry® is the only rapid, in-practice dry eye test that detects MMP-9, a biomarker for inflammation that is consistently elevated in the tears of dry eye patients. All other dry eye tests measure tear production and stability. InflammaDry® recognises elevated levels of MMP-9 to identify patients that may otherwise be missed with other dry eye testing methods.

Identify Dry Eye

Dry eye disease, or dysfunctional tear syndrome, is an extremely common condition that is often under diagnosed and affects 5-30% of the population ages 50 and over.

InflammaDry® is the first and only, rapid, in-practice test that detects MMP-9, an inflammatory marker that is consistently elevated in the tears of patients with dry-eye disease.

Commit to making the right diagnosis with an easy-to-use, in-practice, dry eye test that gives accurate results in as little as 10 minutes.

Watch our Information Video

 

  • Detects elevated levels of MMP-9 in tear fluid, to identify inflammation.
  • Provides rapid results, as soon as 10 minutes.
  • Accurate, with higher sensitivity and specificity, than other dry eye tests.
 

CLINICAL BENEFITS OF IDENTIFYING DRY EYE

 
  • By identifying and treating patients with dry eye, pre-surgical measurements are more accurate and post-surgical outcomes are improved.
  • Reduce post-surgical complications, such as corneal wound healing, by identifying dry eye prior to surgery.
  • Therapeutic treatment of dry eye will improve patient quality of life
 

CONFIDENCE IN DRY EYE DIAGNOSIS

 
  • Disposable, in-practice diagnostic test that requires just 4 easy steps.
  • Low cost test requires no additional equipment to administer or interpret.

RIGHT DIAGNOSIS

  • MMP-9 is a more sensitive diagnostic marker for dry eye than clinical signs alone.
  • Inflammation is present before the clinical signs of dry eye.
  • Increased MMP-9 activity in dry eyes may contribute to deranged corneal epithelial barrier function, increased corneal desquamation, and corneal surface irregularity.

RIGHT TREATMENT

  • Dry eye disease may require an extensive treatment plan and continuous therapy.
  • Artificial tears and punctal occlusion may improve signs and symptoms, while helping to decrease visual irritation. 
  • Anti-inflammatory therapies have been shown to decrease MMP-9 activity.

RIGHT NOW

  • Results as soon as 10 minutes.

Interested in stocking InflammaDry in your practice?


Contact us to find out more about InflammaDry and to order.

T: 08446 696907 
E: info@positiveimpact.co.uk

Latest Events

Scottish Optical Conference

Event Date: 24th November 2019 - 25th November 2019

Event Region:

Glasklar, Dry Eye Zone by Positive Impact and VTI NaturalVue will be attending the Scottish Optical Conference 2019. We'll have exclusive offers for the event as well as our team happy to introduce you to the full range of products we can bring to your practice. 

Read more

HOAC 2019

Event Date: 8th November 2019 - 10th November 2019

Event Region:

Dry Eye Zone by Positive Impact will be attending HOAC 2019. Bringing it's full range of 'Best in Class' portfolio including the new and improved formulation HydraMed. 

Read more

Dry Eye Specialist Club | 1st October

Event Date: 1st October 2019

Event Region:

Dry Eye Zone by Positive Impact will be attending the Dry Eye Specialist Club aswell as the Contact Lens Specialist Club the day before. We hope to be able to discuss the varius treatments/ managements for dry eye and CL induced dry eye, on the day.

Read more

Specialist Club | 30th Sept

Event Date: 30th September 2019

Event Region:

Glasklar, Dry Eye Zone by Positive Impact and VTI NaturalVue will be attending the Specialist Club event at the end of September. We have exclusive offers, competitions and hope to see you there. 

Read more